Geode Capital Management
BBNX

Geode Capital Management’s Beta Bionics BBNX Stock Holding History

Geode Capital Management’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
1,073,452
+140,774
+15% +$1.67M ﹤0.01% 2254
2026
Q1 		$9.35M Buy
932,678
+11,214
+1% +$166K ﹤0.01% 2419
2025
Q4 		$28.1M Buy
921,464
+3,911
+0.4% +$104K ﹤0.01% 1827
2025
Q3 		$18.2M Buy
917,553
+604,623
+193% +$10.6M ﹤0.01% 2044
2025
Q2 		$4.56M Buy
312,930
+6,913
+2% +$97.9K ﹤0.01% 2773
2025
Q1 		$3.75M Buy
+306,017
New +$5.71M ﹤0.01% 2796

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Geode Capital Management's BBNX Position: Q2 2026 in Review

Geode Capital Management increased its Beta Bionics (BBNX) stake by 15% in Q2 2026, buying an estimated $1.67M and bringing the position to 1,073,452 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Geode Capital Management first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $28.1M in Q4 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Geode Capital Management held 1,073,452 shares of Beta Bionics worth $16.8M as of Q2 2026.
  • Geode Capital Management bought 140,774 Beta Bionics shares in Q2 2026, an estimated $1.67M.
  • Beta Bionics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2254 holding.
  • Geode Capital Management first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Geode Capital Management's Beta Bionics position peaked at $28.1M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.